ExitValue.ai

Medical Specialty Valuation Calculator

Backed by 235 real disclosed medical specialtyM&A transactions. Run the full M&A-grade workup in about two minutes.

Value your medical specialty

12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.

  • ✓Sellability score with 5-driver breakdown and lift estimates
  • ✓Named comparable M&A transactions in your sub-vertical
  • ✓AI-written analysis grounded in your specific inputs
Run my valuation analysis →

What this calculator is built on

Disclosed deals analyzed

235

medical specialty M&A transactions

Current market

consolidating

medical specialty trend

Sources

SEC + verified

EDGAR 8-K / S-4 / press

Refresh cadence

Nightly

EDGAR ingest 06:00 UTC

Multiples paid for medical specialty businesses unlock when you run the calculator above - the range is built from these deals.

How this calculator works

The medical specialty calculator analyzes 235 disclosed M&A transactions in our database against your inputs, then applies adjustments specific to medical specialty businesses (margin vs the vertical median, growth trend, recurring revenue mix, owner dependency, customer concentration). Output is a tight range around the most-likely transaction value, with the underlying multiples revealed on the results page.

What drives premium multiples in medical specialty

  • Procedural revenue mix vs E&M-heavy (procedures trade 2-3 turns higher on EBITDA)
  • ASC ownership stake or in-office ancillary (imaging / lab / infusion) as second income leg
  • Multi-physician partnership with associate pipeline (proves transferability to PE / strategic)

What compresses medical specialty multiples

  • Solo practitioner with no associates (kills DSO / PE buyer pool entirely)
  • Single-payer contract above 40% with non-portability clause (multiple compresses 25%+)
  • Narrow geographic catchment area (limits scale story for any consolidator buyer)

More on medical practice specialty valuations

Backed by 25,592 disclosed transactions from SEC filings, EDGAR 8-K/S-4, and verified press releases · methodology